This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2007 May;46(5):730.

doi: 10.1093/rheumatology/kel429. Epub 2007 Feb 19.

Do case control studies on coxibs tell us anything new?

K Brune

PMID: 17309891
DOI: 10.1093/rheumatology/kel429

Editorial

Do case control studies on coxibs tell us anything new?

K Brune. Rheumatology (Oxford). 2007 May.

. 2007 May;46(5):730.

doi: 10.1093/rheumatology/kel429. Epub 2007 Feb 19.

Author

K Brune

PMID: 17309891
DOI: 10.1093/rheumatology/kel429

No abstract available

PubMed Disclaimer

Comment on

Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study.
Rahme E, Nedjar H. Rahme E, et al. Rheumatology (Oxford). 2007 Mar;46(3):435-8. doi: 10.1093/rheumatology/kel428. Epub 2007 Jan 25. Rheumatology (Oxford). 2007. PMID: 17255138

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems